cannabis
cannabis · page 4
- Uncategorized
Key Insights from Mary Jane Berlin x Business of Cannabis’ Inaugural B2B Day
European Cannabis Week 2025 has officially begun, seeing thousands of Europe’s cannabis thought leaders, innovators and decision makers descend on Berlin’s vast Messe Berlin for the first day of Mary Jane Berlin.
- Uncategorized
US Spending Bill Takes Aim at Cannabis Rescheduling Project
As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly veiled attacks on cannabis, this time the ongoing cannabis rescheduling process.
- Data & Analysis
What Comes Next for UK Medical Cannabis?
Though large-scale reform does not currently appear forthcoming, there are small-scale, more targeted measures that could feasibly be taken by UK authorities in the coming years which would be positive for the medical cannabis industry.
- Uncategorized
Much-Needed Or More Delays? UK Industry Responds to Upcoming ACMD Review of Cannabis-Based Medicines
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products.
- Uncategorized
MediPharm On the Brink: Shareholder Revolt Reaches Boiling Point as Board Fight for Survival at Canandian Cannabis Giant
A bitter boardroom battle has erupted at MediPharm Labs, one of Canada’s leading pharmaceutical cannabis companies, as investor Apollo Capital moves to unseat the entire board amid allegations of financial misconduct, mismanagement, and self-enrichment.
- Uncategorized
‘It’s Disneyland for Cannabis’: Mary Jane Berlin Founder on Taking the Grassroots Festival to New Heights
Ahead of Mary Jane Berlin, which returns later this month as part of European Cannabis Week, CEO Duc Anh Dang, spoke to Business of Cannabis about taking the festival to the next level and learning lessons along the way.
- Adult-Use
Czech Republic Moves Closer to Cannabis Decriminalisation with Landmark Law
The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person.
- Uncategorized
Warnings Of Potential Supply Chain Disruptions Following Portuguese Police Bust
As rumours continue to circulate about the identity of the international criminal gang targeted in last week’s Portuguese busts, a key industry player has warned of potential supply disruption to the country’s medical cannabis patients.
- Opinion
Uncertainty Kills: Inside the Cannabis Industry’s Battle with Trump’s Trade War
The shock announcement this week that a federal trade court had ruled that key elements of President Trump’s flagship tariff policy were unconstitutional has come as a major relief for any internationally-facing US business, not least the cannabis sector.
- Uncategorized
Cannabis Debt Crisis Intensifies as Lenders Circle Overleveraged Operators
As spurred lenders begin to encircle cannabis companies owing an estimated $3 billion in collective debt coming due soon, one overleveraged operator is resorting to what observers say are increasingly creative and desperate methods to protect assets from liquidation.
- Adult-Use
Landmark UK Report Recommends Decriminalising Cannabis Possession, Banning Stop & Search, & Cannabis Training for Police
Cannabis possession for personal use should ‘no longer be a criminal offence’, recommends a highly anticipated report led by Lord Charlie Falconer QC.
- Companies
Pharmaceutical Cannabis Steps Into the Spotlight as DanCann, Phytanix and Sandoz Unveil Major Moves
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
